New York Laws
Article 33-A - Controlled Substances Therapeutic Research Act
3397-E - Patient Participation in Program; Procedure.

§ 3397-e. Patient participation in program; procedure. 1. Any
hospital may establish a hospital patient qualification review committee
subject to the rules and regulations promulgated by the commissioner. A
hospital may designate a hospital human research review committee as set
forth in section twenty-four hundred forty-four of this chapter to serve
as a hospital patient qualification review committee.

2. Any physician may recommend a patient for participation in the
Antonio G. Olivieri controlled substances therapeutic research program
to the hospital patient qualification review committee for the hospital
wherein such patient has received medical treatment.

3. The hospital patient qualification review committee shall review
each recommendation and shall submit approved patient applications to
the state patient qualification review board.

4. The state patient qualification review board shall review all
physician applicants for the Antonio G. Olivieri controlled substances
therapeutic research program and certify or refuse to certify their
participation in the program.

5. The state patient qualification review board may delegate to a
hospital patient qualification review committee the authority to approve
or disapprove a patient's participation in such program.

6. A patient shall not be eligible to participate in such program
without the approval of the state patient qualification review board or
the hospital patient qualification review committee delegated pursuant
to subdivision five of this section.

7. The hospital human research review committee shall review each
human research project proposed hereunder and shall certify to the
hospital patient qualification review committee that such project meets
the requirements of this article and article twenty-four-A of this
chapter.

Structure New York Laws